Department of Internal Medicine, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY 11554, United States of America; Department of Internal Medicine, Division of Pulmonary and Critical Care, Nassau University Medical Center, East Meadow, New York, United States of America.
Department of Internal Medicine, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY 11554, United States of America; Department of Internal Medicine, Division of Pulmonary and Critical Care, Nassau University Medical Center, East Meadow, New York, United States of America.
Heart Lung. 2022 Jan-Feb;51:14-16. doi: 10.1016/j.hrtlng.2021.10.001. Epub 2021 Oct 9.
Myopericarditis is a rare consequence of COVID-19 infection. Although extremely rare, COVID-19 can present without pulmonary involvement, and there have been reports of isolated cardiac involvement in one prior case We report a case of a young African American man presenting with myopericarditis following a recently recovered COVID-19 infection. Complicated by ICU admission requiring vasopressors; with eventual resolution following initiation of aspirin and colchicine for myopericarditis. Life threatening myopericarditis can occur following resolution of COVID-19 disease. The degree of cardiac involvement correlates poorly to the severity of pulmonary involvement.
心肌心包炎是 COVID-19 感染的罕见后果。尽管极为罕见，但 COVID-19 也可能不影响肺部而出现，此前有一例报告称存在孤立性心脏受累。我们报告了一例年轻的非裔美国男子，在最近 COVID-19 感染康复后出现心肌心包炎。因心肌心包炎入住 ICU，需要升压药治疗；随后开始使用阿司匹林和秋水仙碱治疗，最终得到缓解。COVID-19 疾病痊愈后也可能发生危及生命的心肌心包炎。心脏受累程度与肺部受累严重程度相关性差。
